Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Enviri Corp, the most common co-covered peer. Orthofix Medical appears in 1 tracked Biotech story from February 24, 2026. The tracked stories average 3 original sources each.
Last mentioned: Feb 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Enviri Corp, the most common co-covered peer. Orthofix Medical appears in 1 tracked Biotech story from February 24, 2026. The tracked stories average 3 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Orthofix Medical. Shared-story counts are live from our verified record — not editorial picks.
Orthofix Medical (OFIX) reported a dual beat on revenue and earnings for the final quarter of 2025, signaling strong momentum in its bone growth and spinal hardware segments. The company’s newly issued FY2026 guidance suggests continued expansion as it consolidates market share following recent leadership transitions.
Orthofix Medical is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
